Products
17546 Results
| Quick actions | ISIN | UL | Product | Direction | SL | Ref. | Bid | Spread | Ask | Ratio | % day | % week | % month | Issue date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis Constant Leverage with ISIN code: CH1276587263 | Novartis | Constant Leverage | Short | ― | 104.02 | 1.76 | 0.020 | 1.78 | 1 | -1.12% | -25.74% | -15.38% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587255 | Novartis | Constant Leverage | Short | ― | 104.02 | 0.5 | 0.020 | 0.52 | 1 | -3.85% | -37.50% | -25.37% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1423416655 | Novartis | Constant Leverage | Short | ― | 104.02 | 0.58 | 0.020 | 0.6 | 1 | -1.69% | -63.75% | -50.85% | 12 May. 2025 | |
| Novartis Constant Leverage with ISIN code: CH1276587248 | Novartis | Constant Leverage | Short | ― | 104.02 | 0.12 | 0.020 | 0.14 | 1 | -14.29% | -47.83% | -36.84% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1423416663 | Novartis | Constant Leverage | Short | ― | 104.02 | 1.07 | 0.020 | 1.09 | 1 | -1.83% | -55.60% | -41.85% | 12 May. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1276587339 | Novo Nordisk | Constant Leverage | Long | ― | 378.051 | 0.024 | ― | ― | 1 | 0.00% | 0.00% | 84.62% | 13 Oct. 2023 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450968495 | Novo Nordisk | Constant Leverage | Long | ― | 378.051 | 12.54 | 0.180 | 12.72 | 1 | -1.42% | 7.64% | -15.67% | 21 Aug. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450967372 | Novo Nordisk | Constant Leverage | Long | ― | 378.051 | 0.003 | ― | ― | 1 | 0.00% | 0.00% | 200.00% | 9 Jul. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993042 | Novo Nordisk | Constant Leverage | Long | ― | 378.051 | 0.009 | ― | ― | 1 | 0.00% | -10.00% | 800.00% | 23 Feb. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993299 | Novo Nordisk | Constant Leverage | Long | ― | 378.051 | 0.009 | ― | ― | 1 | 0.00% | 0.00% | 800.00% | 11 Mar. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450968487 | Novo Nordisk | Constant Leverage | Long | ― | 378.051 | 14.19 | 0.170 | 14.36 | 1 | -1.18% | 9.66% | -3.54% | 21 Aug. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450968479 | Novo Nordisk | Constant Leverage | Long | ― | 378.051 | 14.73 | 0.130 | 14.86 | 1 | -0.87% | 8.71% | 3.51% | 21 Aug. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1396327889 | Novo Nordisk | Constant Leverage | Long | ― | 378.051 | 0.001 | ― | ― | 1 | 0.00% | 0.00% | 0.00% | 29 Jan. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993018 | Novo Nordisk | Constant Leverage | Short | ― | 378.051 | 0.43 | 0.030 | 0.46 | 1 | -6.52% | -30.65% | -47.56% | 23 Feb. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1276587321 | Novo Nordisk | Constant Leverage | Short | ― | 378.051 | 5.33 | 0.090 | 5.42 | 1 | -1.66% | -17.87% | -28.93% | 13 Oct. 2023 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1423415707 | Novo Nordisk | Constant Leverage | Short | ― | 378.051 | 0.24 | 0.030 | 0.27 | 1 | -11.11% | -42.86% | -65.71% | 7 May. 2025 | |
| Nvidia Constant Leverage with ISIN code: CH1423415673 | Nvidia | Constant Leverage | Long | ― | 187.864 | 217.06 | 2.560 | 219.62 | 1 | 1.86% | 62.80% | 69.05% | 7 May. 2025 | |
| Nvidia Constant Leverage with ISIN code: CH1246614460 | Nvidia | Constant Leverage | Long | ― | 187.864 | 4.28 | 0.050 | 4.33 | 1 | 0.94% | 35.02% | 48.61% | 3 Feb. 2023 | |
| Nvidia Constant Leverage with ISIN code: CH1246615640 | Nvidia | Constant Leverage | Long | ― | 187.864 | 0.77 | 0.030 | 0.8 | 1 | 0.00% | 32.76% | 45.28% | 8 Jun. 2023 | |
| Nvidia Constant Leverage with ISIN code: CH1199369815 | Nvidia | Constant Leverage | Long | ― | 187.864 | 27.07 | 0.160 | 27.23 | 1 | 1.05% | 28.90% | 42.47% | 27 Jun. 2022 |
The underlying prices shown are not real-time prices, i.e. they are delayed due to legal requirements of the data provider. As a consequence, the price of the product on a specific underlying may substantially differ from the price of the product that you would expect on the basis of the underlying price displayed.